BRIP1 anticorps (C-Term)
Aperçu rapide pour BRIP1 anticorps (C-Term) (ABIN7469264)
Antigène
Voir toutes BRIP1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Réactivité croisée
- Humain
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogène
- Recombinant protein encompassing a sequence within the C-terminus region of human FANCJ. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB: 1:500-1:3000. IHC-P: 1:100-1:1000. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Commentaires
-
Positive Control: 293T , A431
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1XPBS ( pH 7), 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- BRIP1 (BRCA1 Interacting Protein C-terminal Helicase 1 (BRIP1))
-
Autre désignation
- FANCJ
-
Sujet
-
Synonyms: BRCA1 interacting protein C-terminal helicase 1 , BACH1 , FANCJ , OF
Background: The protein encoded by this gene is a member of the RecQ DEAH helicase family and interacts with the BRCT repeats of breast cancer, type 1 (BRCA1). The bound complex is important in the normal double-strand break repair function of breast cancer, type 1 (BRCA1). This gene may be a target of germline cancer-inducing mutations. [provided by RefSeq]
-
Poids moléculaire
- 141 kDa
-
ID gène
- 83990
-
UniProt
- Q9BX63
-
Pathways
- Réparation de l'ADN
Antigène
-